Precision Business Insights (PBI) in its report titled “Global Cytomegalovirus Infection Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

 

The global cytomegalovirus infection treatment market was valued at US$ 1,327.3 Mn in 2018 and growing at a CAGR of XX% over the forecast period owing to increasing prevalence of CMV infections and increasing awareness among the patients regarding the herpes diseases. For instance, mainly CMV effects young children but in United States, half of the adults under age 30 are infected by CMV. The support from the government and development of healthcare infrastructure are expected to support the growth of the market. Moreover, good number of pipeline therapies for that are under the development for the treatment of CMV such as ATA230 (Atara Biotherapeutics), Maribavir (Shire) fuels the growth of the market. However, expiry of patented drugs are expected to restrain the growth of the market.

 

Global cytomegalovirus infection treatment market segmented on the basis of drug class, infection, distribution channel, and region.

 

 

For more sample: https://www.precisionbusinessinsights.com/request-sample?product_id=15678

 

           

Antiviral Drugs segment accounted for higher revenue share

Based on drug class, global cytomegalovirus infection treatment market segmented into Antiviral Drugs, Foscarnet, Cytovene, Vistide, and others. Antiviral drugs segment market accounted US$ XX Mn in 2018 and projected to dominate over the forecast period due to increasing prevalence of the CMV infections and launch of new products in the market. There are number of products under development for the treatment of CMV infections which is expected to enhance the growth of the market in the future years. However, entry of generic drugs are expected to hamper the growth of the market.

 

North America is expected to dominate Global Cytomegalovirus Infection Treatment Market

PBI’s global cytomegalovirus infection treatment market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to regional analysis, North America is expected to account for larger revenue share in 2018 and the same trend is projected to follow over 2019-2025 owing to rapid prevalence of CMV infection. As per Centre for Disease Control and Prevention (CDC), approximately, 80,000 cases of CMV infections were diagnosed in U.S. and Europe. Rising prevalence of cytomegalovirus (CMV) infection in the developing economies and in the areas of lower economic status. Asia-Pacific is anticipated to grow rapidly owing to the large patient pool, and rise in prevalence of many infectious diseases as well as rise in the awareness on cytomegalovirus infections.

Key Developments  

 

In Feb 2017, Merck & Co., Inc. started pivotal Phase 3 clinical study of letermovir, an antiviral investigational drug for treating clinically significant cytomegalovirus Infection.

 

Key player’s profiles in the report are F. Hoffmann-La Roche AG (Switzerland), GlaxoSmithKline plc (U.K.), Merck & Co., Inc. (U.S.), AiCuris Anti-infective Cures GmbH (Germany), Vical, Inc. (U.S.), Chimerix, Inc. (U.S.) and ViroPharma (U.S.)

 

Detailed Segmentation

 

By Drug Class   

• Antiviral Drugs
• Foscarnet
• Cytovene
• Vistide
• Others

By Infection  

• Retinitis
• Pneumonia
• Gastroenteritis
• Others (Mouth Ulcers, Pharyngitis, etc.)

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Others  

Geography

 

• North America

• U.S
• Canada

• Europe

• Germany
• France
• U.K
• Italy
• Spain
• Russia
• Poland
• Rest of Europe

• Asia-Pacific

• Japan
• China
• India
• Australia & New Zealand
• ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
• South Korea
• Rest of Asia-Pacific

• Latin America

• Brazil
• Mexico
• Argentina
• Rest of Latin America

• Middle East and Africa (MEA)

• Gulf Cooperation Council (GCC) Countries
• Israel
• South Africa
• Rest of MEA

 

 

 

For more information: https://www.precisionbusinessinsights.com/market-reports/global-cytomegalovirus-infection-treatment-market/

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customized market research services based on our client needs.

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com